Kalish Mullen

Since joining Kirkland, Kalish has worked on the following matters:

• KKR-backed April to complete €1.4 billion refinancing.
• Parts Europe on its €1.2 billion refinancing.
• Searchlight Capital on a €307 million recapitalization of Latécoère.
• SK Capital Partners on the $538 million sale of IPACKCHEM.
• Vantiva Technologies on the implementation of an €85 million bridge facility.
• Banijay to complete €910 million bond refinancing.
• IDEMIA Group on the amendment and extension of its revolving credit facility and cross-border TLB facilities.
• HgCapital on its majority investment in Nomadia.
• Metaco on its sale to Ripple.
• Banijay Group to amend, extend and upsize its senior secured debt.
• Cinven Capital Management-Backed ETC Group on the financing to support the acquisitions of Amadys and BTV Multimedia.
• Core Equity Holdings and the Provalliance Group on its refinancing.
• Technicolor on the spinoff and listing of its creative visual arts services division.
• Parts Europe on its new €180 million super senior revolving credit facility entered into in connection with the acquisition of Parts Holding Europe by D’Ieteren Group S.A.
• Platinum Equity on the acquisition of High Temperature Solutions Business.
• BC Partners on the financing of the acquisition of a majority stake in Havea. 
• Main Street Capital on the financing for the acquisition of Critical Mention. 
• Cinven on the financing for the acquisition of ETC Group. 
• UserZoom, a portfolio company of Thoma Bravo, on the acquisition of Testapic.

Prior to joining Kirkland, Kalish’s experience includes advising:

• Infravia on the €425 million financing of its acquisition of Grandir from Eurazeo.
• Montagu on the financing of its acquisition of IMV Technologies from Qualium Investissement.
• Orange on the implementation of a €1.2 billion staple financing relating to the disposal of 50% of its subsidiary operating its rural fixed fibre infrastructure assets and comprising of 23 public initiative networks.
• LFPI and Montefiore on the disposal of MyFlower (including Interflora) to PAI Partners.
• Elsan Group on:
  • the €350 million financing of its acquisition of Groupe C2S from Eurazeo; and
  • the extension of its senior indebtedness, the incorporation of a portability feature and the raising of a €100 million additional facility.
• 3i and Havea Group on:
  • the amendment and extension of its senior facilities;
  • the financing of the acquisition of Pasquali Healthcare;
  • the raising of a €25 million incremental facility; and
  • the financing of the acquisition of ERSA Group.
• Terreal on:
  • the €90 million financing of its acquisition of Creaton from Etex; and
  • the €374 million refinancing of its senior indebtedness with the proceeds of a first lien and second lien financing.
• CVC Capital on its disposal of Elsan Group.
• Ceva Santé Animale on:
  • its €600 million payment in kind financing in the context of a new investment round;
  • the refinancing of its senior indebtedness with the proceeds of a new €2 billion term loan B facility and €150 million revolving credit facility; and
  • its €600 million incremental facility.
• Kiloutou on:
  • the refinancing of its senior indebtedness with the issuance of high yield bonds and the implementation of a super senior revolving credit facility; and
  • the raising of a €150 million incremental facility.
• Pisto on the financing of its acquisition of a 30% shareholding in Société des Transports Pétroliers par Pipeline Trapil.
• IGM Resins on the repricing of its senior indebtedness, the raising of a €65 million incremental facility and the repayment of its second lien indebtedness.
• Montagu on its disposal of Nemera to Astorg.
• Ardian on the financing of its acquisition of Opteven.
• Chequers Capital in relation to its disposal of IdVerde to Core Equity.
• Pisto on the refinancing of its senior indebtedness with a new €622 million facility.
• Astorg on the €310 million first lien financing and €65 million second lien financing of its acquisition of IGM Resins.
• Sanofi on the financing of its €3.9 billion public offer and acquisition of Ablynx, a Belgian listed company.
• HLDI and HLD Europe on the financing of their €1.5 billion acquisition of Kiloutou.
• CVC and Elsan Group on the €730 million financing of Elsan’s acquisition of Groupe Médipôle.
• Chequers Capital on the unitranche financing of its acquisition of Alkern.

Other

• Several portfolio companies on the repricing of their senior facilities.
• Several portfolio companies on the incurrence of state guaranteed loans (prêts garantis par l’Etat).

Weil, Gotshal & Manges LLP, Paris

• Counsel (2021)
• Associate (2016–2020)

Reed Smith LLP, London & Paris

• Associate (2014–2016)
• Trainee Solicitor (2012–2014)